ANI Pharmaceuticals (ANIP) News Today $72.95 +2.26 (+3.20%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$72.96 +0.00 (+0.01%) As of 05/2/2025 04:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period ANI Pharmaceuticals (ANIP) Projected to Post Earnings on FridayANI Pharmaceuticals (NASDAQ:ANIP) will be releasing its Q1 2025 earnings before the market opens on Friday, May 9. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-9-ani-pharmaceuticals-inc-stock/)May 4 at 1:35 AM | marketbeat.comAnalysts Set ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Target Price at $80.13May 4 at 1:07 AM | americanbankingnews.comANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Given Consensus Recommendation of "Buy" by BrokeragesANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Get Free Report) has been given a consensus rating of "Buy" by the nine research firms that are presently covering the company, Marketbeat reports. One analyst has rated the stock with a hold rating, seven have assigned a buy rating and one has given a stMay 3 at 1:11 AM | marketbeat.comANI Pharmaceuticals (NASDAQ:ANIP) Sees Large Volume Increase - Still a Buy?ANI Pharmaceuticals (NASDAQ:ANIP) Sees Unusually-High Trading Volume - Still a Buy?April 30, 2025 | marketbeat.comRaymond James Financial Inc. Invests $3.92 Million in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Raymond James Financial Inc. bought a new position in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 70,826 shares of the specialty pharmaceuApril 29, 2025 | marketbeat.comGeneric Pharmaceuticals Stocks Q4 Teardown: Viatris (NASDAQ:VTRS) Vs The RestApril 28, 2025 | msn.comANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Shares Bought by Oberweis Asset Management Inc.Oberweis Asset Management Inc. lifted its stake in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 50.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 65,600 shares of the specialty phaApril 27, 2025 | marketbeat.comCanada Pension Plan Investment Board Buys New Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Canada Pension Plan Investment Board bought a new position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 30,700 shares of the specialty pharmaceutical company's stocApril 26, 2025 | marketbeat.comBarclays PLC Boosts Stock Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Barclays PLC boosted its position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 9.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 157,060 shares of the specialty pharmaceutical company's stock after buApril 26, 2025 | marketbeat.comANI Pharmaceuticals (NASDAQ:ANIP) Cut to Sell at StockNews.comStockNews.com downgraded ANI Pharmaceuticals from a "hold" rating to a "sell" rating in a report on Thursday.April 26, 2025 | marketbeat.comInvesco Ltd. Cuts Stake in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Invesco Ltd. lessened its stake in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 10.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 197,545 shares of the specialty pharmaceutical company's stoApril 25, 2025 | marketbeat.comANI Pharmaceuticals (NASDAQ:ANIP) Lowered to Sell Rating by StockNews.comApril 24, 2025 | americanbankingnews.comTruist Financial Issues Positive Forecast for ANI Pharmaceuticals (NASDAQ:ANIP) Stock PriceTruist Financial upped their price target on shares of ANI Pharmaceuticals from $62.00 to $65.00 and gave the company a "hold" rating in a research report on Monday.April 23, 2025 | marketbeat.comANI Pharmaceuticals price target raised to $65 from $62 at TruistApril 22, 2025 | markets.businessinsider.comGeode Capital Management LLC Acquires 3,774 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Geode Capital Management LLC increased its holdings in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 0.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 428,999 shares of the speciApril 21, 2025 | marketbeat.comWalleye Capital LLC Takes Position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Walleye Capital LLC bought a new position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 72,009 shares of the specialty pharmaceutical company's stock, valuedApril 19, 2025 | marketbeat.comRenaissance Technologies LLC Sells 69,302 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Renaissance Technologies LLC lowered its position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 28.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 175,800 shares of the specialty pharmaceutical company's stoApril 19, 2025 | marketbeat.comANI Pharmaceuticals (NASDAQ:ANIP) Raised to Hold at StockNews.comStockNews.com raised ANI Pharmaceuticals from a "sell" rating to a "hold" rating in a research report on Wednesday.April 18, 2025 | marketbeat.comANI Pharmaceuticals (NASDAQ:ANIP) Hits New 52-Week High - Still a Buy?ANI Pharmaceuticals (NASDAQ:ANIP) Hits New 52-Week High - Still a Buy?April 18, 2025 | marketbeat.comXTX Topco Ltd Invests $997,000 in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)XTX Topco Ltd acquired a new stake in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The fund acquired 18,029 shares of the specialty pharmaceutical company's stock, valued at approximately $997,000. XApril 18, 2025 | marketbeat.comANI Pharmaceuticals, Inc. (NASDAQ:ANIP) VP Sells $27,584.00 in StockANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Get Free Report) VP Meredith Cook sold 400 shares of the company's stock in a transaction dated Monday, April 14th. The stock was sold at an average price of $68.96, for a total transaction of $27,584.00. Following the completion of the sale, the vice president now owns 80,145 shares in the company, valued at approximately $5,526,799.20. This trade represents a 0.50 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.April 16, 2025 | marketbeat.comANI Pharmaceuticals (ANIP): Buy, Sell, or Hold Post Q4 Earnings?April 16, 2025 | uk.finance.yahoo.comBank of Montreal Can Acquires 8,257 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Bank of Montreal Can lifted its holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 3.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 230,153 shares of the specialty pharmaceutical coApril 15, 2025 | marketbeat.comRussell Investments Group Ltd. Sells 17,462 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Russell Investments Group Ltd. cut its position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 11.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 140,496 shares of the specialty pharmaceutical company's sApril 15, 2025 | marketbeat.comMartingale Asset Management L P Sells 8,563 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Martingale Asset Management L P lessened its holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 24.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 26,177 shares of the specialty pharmaceutical companyApril 14, 2025 | marketbeat.comJPMorgan Chase & Co. Sells 286,785 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)JPMorgan Chase & Co. decreased its holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 51.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 268,050 shares of the specialty pharmaceutical cApril 14, 2025 | marketbeat.comANI Pharmaceuticals (NASDAQ:ANIP) Given Buy Rating at GuggenheimGuggenheim restated a "buy" rating and set a $86.00 price objective on shares of ANI Pharmaceuticals in a report on Friday.April 13, 2025 | marketbeat.comLeerink Partnrs Weighs in on ANIP Q1 EarningsANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) - Equities researchers at Leerink Partnrs issued their Q1 2025 earnings estimates for shares of ANI Pharmaceuticals in a research note issued to investors on Wednesday, April 9th. Leerink Partnrs analyst F. Khurshid anticipates that the speciaApril 13, 2025 | marketbeat.comF M Investments LLC Trims Position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)F M Investments LLC decreased its holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 8.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 56,313 shares of the specialty pharmaceutical company's stockApril 13, 2025 | marketbeat.comVanguard Group Inc. Lowers Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Vanguard Group Inc. lowered its position in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 2.5% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,314,372 shares of the specialty pharmaceutical company's stock after selliApril 13, 2025 | marketbeat.comGuggenheim Sticks to Its Buy Rating for ANI Pharmaceuticals (ANIP)April 12, 2025 | markets.businessinsider.comDeep Dive Into ANI Pharmaceuticals Stock: Analyst Perspectives (6 Ratings)April 11, 2025 | benzinga.comRanger Investment Management L.P. Has $31.94 Million Stock Position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Ranger Investment Management L.P. reduced its position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 2.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 577,738 shares of the specialty pharmaApril 11, 2025 | marketbeat.comANI Pharmaceuticals (NASDAQ:ANIP) Downgraded by StockNews.com to "Sell"StockNews.com cut shares of ANI Pharmaceuticals from a "hold" rating to a "sell" rating in a research note on Tuesday.April 10, 2025 | marketbeat.comANI Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 9, 2025, at 8:00 a.m. ETApril 9, 2025 | globenewswire.comHeadlands Technologies LLC Has $66,000 Position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Headlands Technologies LLC lessened its holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 85.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,198 shares of the specialty pharmaceutical coApril 9, 2025 | marketbeat.comIntegrated Quantitative Investments LLC Buys Shares of 4,900 ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Integrated Quantitative Investments LLC purchased a new position in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 4,900 shares of the specialty phaApril 8, 2025 | marketbeat.comANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Stock Holdings Decreased by American Century Companies Inc.American Century Companies Inc. lessened its position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 31.1% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 60,248 shares of the specialty pharmaceutical company's stocApril 8, 2025 | marketbeat.comANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Given Average Rating of "Buy" by BrokeragesShares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Get Free Report) have received a consensus recommendation of "Buy" from the nine brokerages that are presently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation, seven have issuApril 7, 2025 | marketbeat.comANI Pharmaceuticals to Present at 2025 RBC Capital Markets Ophthalmology Virtual ConferenceMarch 31, 2025 | globenewswire.comANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Shares Acquired by Loomis Sayles & Co. L PLoomis Sayles & Co. L P increased its stake in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 11.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 194,185 shares of the specMarch 31, 2025 | marketbeat.comANI Pharmaceuticals (NASDAQ:ANIP) Stock Price Up 3.1% - Here's What HappenedANI Pharmaceuticals (NASDAQ:ANIP) Stock Price Up 3.1% - Here's WhyMarch 27, 2025 | marketbeat.comRaymond James Financial Inc. Acquires New Position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Raymond James Financial Inc. acquired a new stake in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm acquired 70,826 shares of the specialty pharmaceutical company's stock, valued at approximatelyMarch 27, 2025 | marketbeat.comIntech Investment Management LLC Has $983,000 Stock Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Intech Investment Management LLC raised its holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 41.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 17,780 shares of the specialty pharmaceutical compMarch 23, 2025 | marketbeat.comANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Shares Sold by AlphaQuest LLCAlphaQuest LLC decreased its holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 94.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 516 shares of the specialty pharmaceutical company's stock after selling 9,377 shares dMarch 22, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Trims Stock Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Charles Schwab Investment Management Inc. reduced its position in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 5.7% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 236,157 shares of the specialty phaMarch 22, 2025 | marketbeat.comANI Pharmaceuticals, Inc.: ANI Pharmaceuticals Announces the Launch of Nitazoxanide TabletsMarch 19, 2025 | finanznachrichten.deANI Pharmaceuticals launches Nitazoxanide Tablets, 500 mg.March 19, 2025 | markets.businessinsider.comANI Pharmaceuticals Announces the Launch of Nitazoxanide TabletsMarch 19, 2025 | globenewswire.comANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Position Increased by William Blair Investment Management LLCWilliam Blair Investment Management LLC increased its position in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 2.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 48March 19, 2025 | marketbeat.com Get ANI Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIP and its competitors with MarketBeat's FREE daily newsletter. Email Address ANIP Media Mentions By Week ANIP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANIP News Sentiment▼0.840.73▲Average Medical News Sentiment ANIP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANIP Articles This Week▼66▲ANIP Articles Average Week Get ANI Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Sarepta Therapeutics News Telix Pharmaceuticals Limited American Depositary Shares News ADMA Biologics News Blueprint Medicines News Verona Pharma News Nuvalent News Axsome Therapeutics News Grifols News Cytokinetics News Krystal Biotech News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ANIP) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredElon Musk is all in on these robots …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ANI Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ANI Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ANIP Stock Free ANIP Stock Alerts